DPC Biosciences Corporation

January 12, 2006 16:54 ET

DPC Biosciences Corporation Closes Private Placement and Sells Wholly Owned Subsidiary

VANCOUVER, BRITISH COLUMBIA--(CCNMatthews - Jan. 12, 2006) - Christopher Kape, President and CEO of DPC Biosciences Corporation (the "Company" or "DPC") (NEX BOARD:DPC.H) announces today that the first round of the non brokered private placement in the amount of $150,000 at $0.05 per share has closed. The Company has announced that it will endeavour to raise an additional $300,000 by January 30, 2006, as stated in its initial news release relating to the private placement on December 20, 2005.

The President also reports that the Company has sold all of the issued and paid up capital stock in its wholly owned subsidiary, DPC Biosciences Inc., to 0743094 B.C. Ltd, in consideration for the purchase price of $10 and the cancellation of all outstanding indebtedness.

The TSX Venture Exchange does not accept responsibility for the adequacy or the accuracy of the information contanied in the news release.

Contact Information